Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma - PDF (Russian)

Copyright (c) 2020 Bolotina L.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies